Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.
Laboratory of Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.
Lancet Diabetes Endocrinol. 2021 Nov;9(11):776-785. doi: 10.1016/S2213-8587(21)00246-1. Epub 2021 Sep 30.
Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. Non-physiological insulin replacement that causes peripheral hyperinsulinaemia, insulin profiles that do not match basal and mealtime insulin needs, defensive snacking to avoid hypoglycaemia, or a combination of these, are believed to affect body composition and drive excessive accumulation of body fat in people with type 1 diabetes. The consequences of overweight or obesity in people with type 1 diabetes are of particular concern, as they increase the risk of both diabetes-related and obesity-related complications, including cardiovascular disease, stroke, and various types of cancer. In this Review, we summarise the current understanding of the aetiology and consequences of excessive bodyweight in people with type 1 diabetes and highlight the need to optimise future prevention and treatment strategies in this population.
尽管 1 型糖尿病传统上被认为是瘦人的疾病,但超重和肥胖在 1 型糖尿病患者中越来越常见。非生理性胰岛素替代导致外周高胰岛素血症、与基础和餐时胰岛素需求不匹配的胰岛素谱、为避免低血糖而进行的防御性小吃,或这些因素的组合,据信会影响身体成分并导致 1 型糖尿病患者体内脂肪过度堆积。超重或肥胖对 1 型糖尿病患者的后果尤其令人关注,因为它们会增加与糖尿病和肥胖相关的并发症的风险,包括心血管疾病、中风和各种类型的癌症。在这篇综述中,我们总结了目前对 1 型糖尿病患者体重过重的病因和后果的理解,并强调需要优化这一人群的未来预防和治疗策略。